EFFECTIVE Act

12/15/2023, 3:55 PM

Summary of Bill HR 1375

The EFFECTIVE Act, also known as Bill 118 hr 1375, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to enhance the effectiveness of federal programs that aim to reduce poverty and improve economic mobility for low-income individuals and families.

One key provision of the EFFECTIVE Act is the establishment of a commission that will be responsible for evaluating the impact of federal anti-poverty programs. This commission will conduct rigorous evaluations of these programs to determine their effectiveness in helping individuals and families move out of poverty and achieve economic stability.

Additionally, the EFFECTIVE Act includes measures to increase transparency and accountability in federal anti-poverty programs. This includes requiring program administrators to regularly report on the outcomes of their programs and to make this information publicly available. This will allow policymakers and the public to better understand which programs are working and which may need to be reformed or eliminated. Overall, the EFFECTIVE Act aims to ensure that federal anti-poverty programs are achieving their intended goals and are making a meaningful impact on the lives of low-income individuals and families. By increasing transparency, accountability, and evaluation of these programs, the bill seeks to improve the effectiveness of federal efforts to reduce poverty and promote economic mobility in the United States.

Current Status of Bill HR 1375

Bill HR 1375 is currently in the status of Bill Introduced since March 3, 2023. Bill HR 1375 was introduced during Congress 118 and was introduced to the House on March 3, 2023.  Bill HR 1375's most recent activity was Referred to the Subcommittee on Health. as of March 10, 2023

Bipartisan Support of Bill HR 1375

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 1375

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 1375

EFFECTIVE ActEFFECTIVE ActEnsuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement ActTo allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
Start holding our government accountable!

Comments